Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bioniche Purchase Will Move Mylan Into Generic Injectables Market

This article was originally published in The Pink Sheet Daily

Executive Summary

Bioniche Pharma will be combined with UDL Laboratories to create new Mylan Institutional unit.
Advertisement

Related Content

Three Largest U.S. Generic Firms See Diversification As Best Path Through Reverse Patent Cliff
Mylan's Acquisition Strategy Now Focuses On "Bolt-Ons"
Mylan's Acquisition Strategy Now Focuses On "Bolt-Ons"
Deals Of The Week: Mylan/Bioniche; Watson/Itero; Genentech/MRC Technology...
Deals Of The Week: Mylan/Bioniche; Watson/Itero; Genentech/MRC Technology...
Generic Injectables: Pharma Takes A Shot At A Growing Market
Generic Injectables: Pharma Takes A Shot At A Growing Market
Playing Catch-Up: Mylan And Biocon To Team Up On Generic Biologics

Topics

Advertisement
UsernamePublicRestriction

Register

PS070899

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel